nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—CYP3A4—bone cancer	0.848	1	CbGaD
Darunavir—Fosamprenavir—CYP3A4—bone cancer	0.00465	0.707	CrCbGaD
Darunavir—Amprenavir—CYP3A4—bone cancer	0.00193	0.293	CrCbGaD
Darunavir—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00022	0.00152	CcSEcCtD
Darunavir—Pancytopenia—Doxorubicin—bone cancer	0.000219	0.00151	CcSEcCtD
Darunavir—Renal failure—Epirubicin—bone cancer	0.000218	0.0015	CcSEcCtD
Darunavir—Body temperature increased—Cisplatin—bone cancer	0.000218	0.0015	CcSEcCtD
Darunavir—Neuropathy peripheral—Epirubicin—bone cancer	0.000218	0.0015	CcSEcCtD
Darunavir—Stomatitis—Epirubicin—bone cancer	0.000217	0.00149	CcSEcCtD
Darunavir—Jaundice—Epirubicin—bone cancer	0.000217	0.00149	CcSEcCtD
Darunavir—Dysuria—Doxorubicin—bone cancer	0.000216	0.00148	CcSEcCtD
Darunavir—Neutropenia—Doxorubicin—bone cancer	0.000216	0.00148	CcSEcCtD
Darunavir—Haemoglobin—Methotrexate—bone cancer	0.000214	0.00147	CcSEcCtD
Darunavir—Hepatitis—Methotrexate—bone cancer	0.000213	0.00147	CcSEcCtD
Darunavir—Haemorrhage—Methotrexate—bone cancer	0.000213	0.00147	CcSEcCtD
Darunavir—Pollakiuria—Doxorubicin—bone cancer	0.000213	0.00147	CcSEcCtD
Darunavir—Haematuria—Epirubicin—bone cancer	0.000212	0.00146	CcSEcCtD
Darunavir—Urinary tract disorder—Methotrexate—bone cancer	0.000211	0.00145	CcSEcCtD
Darunavir—Hepatobiliary disease—Epirubicin—bone cancer	0.00021	0.00145	CcSEcCtD
Darunavir—Weight increased—Doxorubicin—bone cancer	0.00021	0.00144	CcSEcCtD
Darunavir—Epistaxis—Epirubicin—bone cancer	0.00021	0.00144	CcSEcCtD
Darunavir—Urethral disorder—Methotrexate—bone cancer	0.000209	0.00144	CcSEcCtD
Darunavir—Weight decreased—Doxorubicin—bone cancer	0.000209	0.00144	CcSEcCtD
Darunavir—Hyperglycaemia—Doxorubicin—bone cancer	0.000208	0.00143	CcSEcCtD
Darunavir—Infestation NOS—Doxorubicin—bone cancer	0.000206	0.00142	CcSEcCtD
Darunavir—Infestation—Doxorubicin—bone cancer	0.000206	0.00142	CcSEcCtD
Darunavir—Visual impairment—Methotrexate—bone cancer	0.000205	0.00141	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000204	0.0014	CcSEcCtD
Darunavir—Hypersensitivity—Cisplatin—bone cancer	0.000203	0.0014	CcSEcCtD
Darunavir—Bradycardia—Epirubicin—bone cancer	0.000203	0.0014	CcSEcCtD
Darunavir—Renal failure—Doxorubicin—bone cancer	0.000202	0.00139	CcSEcCtD
Darunavir—Erythema multiforme—Methotrexate—bone cancer	0.000202	0.00139	CcSEcCtD
Darunavir—Neuropathy peripheral—Doxorubicin—bone cancer	0.000202	0.00139	CcSEcCtD
Darunavir—Haemoglobin—Epirubicin—bone cancer	0.000201	0.00138	CcSEcCtD
Darunavir—Stomatitis—Doxorubicin—bone cancer	0.0002	0.00138	CcSEcCtD
Darunavir—Jaundice—Doxorubicin—bone cancer	0.0002	0.00138	CcSEcCtD
Darunavir—Haemorrhage—Epirubicin—bone cancer	0.0002	0.00137	CcSEcCtD
Darunavir—Hepatitis—Epirubicin—bone cancer	0.0002	0.00137	CcSEcCtD
Darunavir—Eye disorder—Methotrexate—bone cancer	0.000199	0.00137	CcSEcCtD
Darunavir—Hypoaesthesia—Epirubicin—bone cancer	0.000199	0.00137	CcSEcCtD
Darunavir—Asthenia—Cisplatin—bone cancer	0.000198	0.00136	CcSEcCtD
Darunavir—Cardiac disorder—Methotrexate—bone cancer	0.000198	0.00136	CcSEcCtD
Darunavir—Urinary tract disorder—Epirubicin—bone cancer	0.000197	0.00136	CcSEcCtD
Darunavir—Oedema peripheral—Epirubicin—bone cancer	0.000197	0.00135	CcSEcCtD
Darunavir—Haematuria—Doxorubicin—bone cancer	0.000196	0.00135	CcSEcCtD
Darunavir—Connective tissue disorder—Epirubicin—bone cancer	0.000196	0.00135	CcSEcCtD
Darunavir—Urethral disorder—Epirubicin—bone cancer	0.000196	0.00135	CcSEcCtD
Darunavir—Hepatobiliary disease—Doxorubicin—bone cancer	0.000194	0.00134	CcSEcCtD
Darunavir—Epistaxis—Doxorubicin—bone cancer	0.000194	0.00133	CcSEcCtD
Darunavir—Angiopathy—Methotrexate—bone cancer	0.000193	0.00133	CcSEcCtD
Darunavir—Immune system disorder—Methotrexate—bone cancer	0.000193	0.00133	CcSEcCtD
Darunavir—Visual impairment—Epirubicin—bone cancer	0.000192	0.00132	CcSEcCtD
Darunavir—Mediastinal disorder—Methotrexate—bone cancer	0.000192	0.00132	CcSEcCtD
Darunavir—Chills—Methotrexate—bone cancer	0.000191	0.00132	CcSEcCtD
Darunavir—Diarrhoea—Cisplatin—bone cancer	0.000189	0.0013	CcSEcCtD
Darunavir—Erythema multiforme—Epirubicin—bone cancer	0.000189	0.0013	CcSEcCtD
Darunavir—Alopecia—Methotrexate—bone cancer	0.000188	0.0013	CcSEcCtD
Darunavir—Bradycardia—Doxorubicin—bone cancer	0.000188	0.00129	CcSEcCtD
Darunavir—Mental disorder—Methotrexate—bone cancer	0.000187	0.00129	CcSEcCtD
Darunavir—Eye disorder—Epirubicin—bone cancer	0.000186	0.00128	CcSEcCtD
Darunavir—Erythema—Methotrexate—bone cancer	0.000186	0.00128	CcSEcCtD
Darunavir—Malnutrition—Methotrexate—bone cancer	0.000186	0.00128	CcSEcCtD
Darunavir—Haemoglobin—Doxorubicin—bone cancer	0.000186	0.00128	CcSEcCtD
Darunavir—Flushing—Epirubicin—bone cancer	0.000185	0.00127	CcSEcCtD
Darunavir—Cardiac disorder—Epirubicin—bone cancer	0.000185	0.00127	CcSEcCtD
Darunavir—Hepatitis—Doxorubicin—bone cancer	0.000185	0.00127	CcSEcCtD
Darunavir—Haemorrhage—Doxorubicin—bone cancer	0.000185	0.00127	CcSEcCtD
Darunavir—Hypoaesthesia—Doxorubicin—bone cancer	0.000184	0.00126	CcSEcCtD
Darunavir—Urinary tract disorder—Doxorubicin—bone cancer	0.000182	0.00125	CcSEcCtD
Darunavir—Oedema peripheral—Doxorubicin—bone cancer	0.000182	0.00125	CcSEcCtD
Darunavir—Dysgeusia—Methotrexate—bone cancer	0.000182	0.00125	CcSEcCtD
Darunavir—Connective tissue disorder—Doxorubicin—bone cancer	0.000181	0.00125	CcSEcCtD
Darunavir—Angiopathy—Epirubicin—bone cancer	0.000181	0.00125	CcSEcCtD
Darunavir—Urethral disorder—Doxorubicin—bone cancer	0.000181	0.00125	CcSEcCtD
Darunavir—Immune system disorder—Epirubicin—bone cancer	0.00018	0.00124	CcSEcCtD
Darunavir—Mediastinal disorder—Epirubicin—bone cancer	0.00018	0.00124	CcSEcCtD
Darunavir—Chills—Epirubicin—bone cancer	0.000179	0.00123	CcSEcCtD
Darunavir—Visual impairment—Doxorubicin—bone cancer	0.000178	0.00122	CcSEcCtD
Darunavir—Alopecia—Epirubicin—bone cancer	0.000176	0.00121	CcSEcCtD
Darunavir—Vomiting—Cisplatin—bone cancer	0.000176	0.00121	CcSEcCtD
Darunavir—Mental disorder—Epirubicin—bone cancer	0.000175	0.0012	CcSEcCtD
Darunavir—Erythema multiforme—Doxorubicin—bone cancer	0.000175	0.0012	CcSEcCtD
Darunavir—Rash—Cisplatin—bone cancer	0.000174	0.0012	CcSEcCtD
Darunavir—Dermatitis—Cisplatin—bone cancer	0.000174	0.0012	CcSEcCtD
Darunavir—Erythema—Epirubicin—bone cancer	0.000174	0.0012	CcSEcCtD
Darunavir—Malnutrition—Epirubicin—bone cancer	0.000174	0.0012	CcSEcCtD
Darunavir—Eye disorder—Doxorubicin—bone cancer	0.000173	0.00119	CcSEcCtD
Darunavir—Ill-defined disorder—Methotrexate—bone cancer	0.000172	0.00119	CcSEcCtD
Darunavir—Anaemia—Methotrexate—bone cancer	0.000172	0.00118	CcSEcCtD
Darunavir—Flushing—Doxorubicin—bone cancer	0.000171	0.00118	CcSEcCtD
Darunavir—Cardiac disorder—Doxorubicin—bone cancer	0.000171	0.00118	CcSEcCtD
Darunavir—Flatulence—Epirubicin—bone cancer	0.000171	0.00118	CcSEcCtD
Darunavir—Dysgeusia—Epirubicin—bone cancer	0.00017	0.00117	CcSEcCtD
Darunavir—Angiopathy—Doxorubicin—bone cancer	0.000167	0.00115	CcSEcCtD
Darunavir—Malaise—Methotrexate—bone cancer	0.000167	0.00115	CcSEcCtD
Darunavir—Muscle spasms—Epirubicin—bone cancer	0.000167	0.00115	CcSEcCtD
Darunavir—Immune system disorder—Doxorubicin—bone cancer	0.000167	0.00115	CcSEcCtD
Darunavir—Vertigo—Methotrexate—bone cancer	0.000167	0.00115	CcSEcCtD
Darunavir—Mediastinal disorder—Doxorubicin—bone cancer	0.000166	0.00114	CcSEcCtD
Darunavir—Leukopenia—Methotrexate—bone cancer	0.000166	0.00114	CcSEcCtD
Darunavir—Chills—Doxorubicin—bone cancer	0.000166	0.00114	CcSEcCtD
Darunavir—Nausea—Cisplatin—bone cancer	0.000164	0.00113	CcSEcCtD
Darunavir—Alopecia—Doxorubicin—bone cancer	0.000163	0.00112	CcSEcCtD
Darunavir—Cough—Methotrexate—bone cancer	0.000162	0.00111	CcSEcCtD
Darunavir—Mental disorder—Doxorubicin—bone cancer	0.000162	0.00111	CcSEcCtD
Darunavir—Ill-defined disorder—Epirubicin—bone cancer	0.000161	0.00111	CcSEcCtD
Darunavir—Convulsion—Methotrexate—bone cancer	0.000161	0.00111	CcSEcCtD
Darunavir—Erythema—Doxorubicin—bone cancer	0.000161	0.00111	CcSEcCtD
Darunavir—Malnutrition—Doxorubicin—bone cancer	0.000161	0.00111	CcSEcCtD
Darunavir—Anaemia—Epirubicin—bone cancer	0.000161	0.0011	CcSEcCtD
Darunavir—Agitation—Epirubicin—bone cancer	0.00016	0.0011	CcSEcCtD
Darunavir—Flatulence—Doxorubicin—bone cancer	0.000158	0.00109	CcSEcCtD
Darunavir—Chest pain—Methotrexate—bone cancer	0.000158	0.00109	CcSEcCtD
Darunavir—Myalgia—Methotrexate—bone cancer	0.000158	0.00109	CcSEcCtD
Darunavir—Arthralgia—Methotrexate—bone cancer	0.000158	0.00109	CcSEcCtD
Darunavir—Dysgeusia—Doxorubicin—bone cancer	0.000157	0.00108	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000157	0.00108	CcSEcCtD
Darunavir—Malaise—Epirubicin—bone cancer	0.000157	0.00108	CcSEcCtD
Darunavir—Discomfort—Methotrexate—bone cancer	0.000156	0.00107	CcSEcCtD
Darunavir—Vertigo—Epirubicin—bone cancer	0.000156	0.00107	CcSEcCtD
Darunavir—Syncope—Epirubicin—bone cancer	0.000156	0.00107	CcSEcCtD
Darunavir—Leukopenia—Epirubicin—bone cancer	0.000155	0.00107	CcSEcCtD
Darunavir—Muscle spasms—Doxorubicin—bone cancer	0.000155	0.00106	CcSEcCtD
Darunavir—Palpitations—Epirubicin—bone cancer	0.000153	0.00106	CcSEcCtD
Darunavir—Confusional state—Methotrexate—bone cancer	0.000153	0.00105	CcSEcCtD
Darunavir—Loss of consciousness—Epirubicin—bone cancer	0.000153	0.00105	CcSEcCtD
Darunavir—Cough—Epirubicin—bone cancer	0.000152	0.00104	CcSEcCtD
Darunavir—Convulsion—Epirubicin—bone cancer	0.00015	0.00104	CcSEcCtD
Darunavir—Hypertension—Epirubicin—bone cancer	0.00015	0.00103	CcSEcCtD
Darunavir—Ill-defined disorder—Doxorubicin—bone cancer	0.000149	0.00103	CcSEcCtD
Darunavir—Nervous system disorder—Methotrexate—bone cancer	0.000149	0.00102	CcSEcCtD
Darunavir—Anaemia—Doxorubicin—bone cancer	0.000149	0.00102	CcSEcCtD
Darunavir—Thrombocytopenia—Methotrexate—bone cancer	0.000148	0.00102	CcSEcCtD
Darunavir—Myalgia—Epirubicin—bone cancer	0.000148	0.00102	CcSEcCtD
Darunavir—Chest pain—Epirubicin—bone cancer	0.000148	0.00102	CcSEcCtD
Darunavir—Arthralgia—Epirubicin—bone cancer	0.000148	0.00102	CcSEcCtD
Darunavir—Agitation—Doxorubicin—bone cancer	0.000148	0.00102	CcSEcCtD
Darunavir—Anxiety—Epirubicin—bone cancer	0.000147	0.00101	CcSEcCtD
Darunavir—Skin disorder—Methotrexate—bone cancer	0.000147	0.00101	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000147	0.00101	CcSEcCtD
Darunavir—Hyperhidrosis—Methotrexate—bone cancer	0.000146	0.00101	CcSEcCtD
Darunavir—Discomfort—Epirubicin—bone cancer	0.000146	0.00101	CcSEcCtD
Darunavir—Malaise—Doxorubicin—bone cancer	0.000145	0.000997	CcSEcCtD
Darunavir—Dry mouth—Epirubicin—bone cancer	0.000145	0.000995	CcSEcCtD
Darunavir—Vertigo—Doxorubicin—bone cancer	0.000144	0.000994	CcSEcCtD
Darunavir—Anorexia—Methotrexate—bone cancer	0.000144	0.000994	CcSEcCtD
Darunavir—Syncope—Doxorubicin—bone cancer	0.000144	0.000992	CcSEcCtD
Darunavir—Leukopenia—Doxorubicin—bone cancer	0.000144	0.00099	CcSEcCtD
Darunavir—Confusional state—Epirubicin—bone cancer	0.000143	0.000984	CcSEcCtD
Darunavir—Palpitations—Doxorubicin—bone cancer	0.000142	0.000977	CcSEcCtD
Darunavir—Loss of consciousness—Doxorubicin—bone cancer	0.000141	0.000972	CcSEcCtD
Darunavir—Cough—Doxorubicin—bone cancer	0.00014	0.000965	CcSEcCtD
Darunavir—Shock—Epirubicin—bone cancer	0.000139	0.00096	CcSEcCtD
Darunavir—Convulsion—Doxorubicin—bone cancer	0.000139	0.000958	CcSEcCtD
Darunavir—Nervous system disorder—Epirubicin—bone cancer	0.000139	0.000957	CcSEcCtD
Darunavir—Thrombocytopenia—Epirubicin—bone cancer	0.000139	0.000955	CcSEcCtD
Darunavir—Hypertension—Doxorubicin—bone cancer	0.000139	0.000955	CcSEcCtD
Darunavir—Tachycardia—Epirubicin—bone cancer	0.000138	0.000952	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000138	0.00095	CcSEcCtD
Darunavir—Skin disorder—Epirubicin—bone cancer	0.000138	0.000947	CcSEcCtD
Darunavir—Hyperhidrosis—Epirubicin—bone cancer	0.000137	0.000943	CcSEcCtD
Darunavir—Insomnia—Methotrexate—bone cancer	0.000137	0.000943	CcSEcCtD
Darunavir—Myalgia—Doxorubicin—bone cancer	0.000137	0.000942	CcSEcCtD
Darunavir—Chest pain—Doxorubicin—bone cancer	0.000137	0.000942	CcSEcCtD
Darunavir—Arthralgia—Doxorubicin—bone cancer	0.000137	0.000942	CcSEcCtD
Darunavir—Anxiety—Doxorubicin—bone cancer	0.000136	0.000938	CcSEcCtD
Darunavir—Paraesthesia—Methotrexate—bone cancer	0.000136	0.000936	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000136	0.000935	CcSEcCtD
Darunavir—Discomfort—Doxorubicin—bone cancer	0.000135	0.00093	CcSEcCtD
Darunavir—Anorexia—Epirubicin—bone cancer	0.000135	0.00093	CcSEcCtD
Darunavir—Dyspnoea—Methotrexate—bone cancer	0.000135	0.000929	CcSEcCtD
Darunavir—Somnolence—Methotrexate—bone cancer	0.000135	0.000927	CcSEcCtD
Darunavir—Dry mouth—Doxorubicin—bone cancer	0.000134	0.000921	CcSEcCtD
Darunavir—Dyspepsia—Methotrexate—bone cancer	0.000133	0.000918	CcSEcCtD
Darunavir—Confusional state—Doxorubicin—bone cancer	0.000132	0.00091	CcSEcCtD
Darunavir—Decreased appetite—Methotrexate—bone cancer	0.000132	0.000906	CcSEcCtD
Darunavir—Gastrointestinal disorder—Methotrexate—bone cancer	0.000131	0.0009	CcSEcCtD
Darunavir—Fatigue—Methotrexate—bone cancer	0.000131	0.000899	CcSEcCtD
Darunavir—Pain—Methotrexate—bone cancer	0.00013	0.000891	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000129	0.000889	CcSEcCtD
Darunavir—Shock—Doxorubicin—bone cancer	0.000129	0.000888	CcSEcCtD
Darunavir—Nervous system disorder—Doxorubicin—bone cancer	0.000129	0.000885	CcSEcCtD
Darunavir—Thrombocytopenia—Doxorubicin—bone cancer	0.000128	0.000884	CcSEcCtD
Darunavir—Insomnia—Epirubicin—bone cancer	0.000128	0.000882	CcSEcCtD
Darunavir—Tachycardia—Doxorubicin—bone cancer	0.000128	0.000881	CcSEcCtD
Darunavir—Skin disorder—Doxorubicin—bone cancer	0.000127	0.000877	CcSEcCtD
Darunavir—Paraesthesia—Epirubicin—bone cancer	0.000127	0.000876	CcSEcCtD
Darunavir—Hyperhidrosis—Doxorubicin—bone cancer	0.000127	0.000873	CcSEcCtD
Darunavir—Dyspnoea—Epirubicin—bone cancer	0.000126	0.00087	CcSEcCtD
Darunavir—Somnolence—Epirubicin—bone cancer	0.000126	0.000867	CcSEcCtD
Darunavir—Anorexia—Doxorubicin—bone cancer	0.000125	0.00086	CcSEcCtD
Darunavir—Feeling abnormal—Methotrexate—bone cancer	0.000125	0.000859	CcSEcCtD
Darunavir—Dyspepsia—Epirubicin—bone cancer	0.000125	0.000859	CcSEcCtD
Darunavir—Gastrointestinal pain—Methotrexate—bone cancer	0.000124	0.000852	CcSEcCtD
Darunavir—Decreased appetite—Epirubicin—bone cancer	0.000123	0.000848	CcSEcCtD
Darunavir—Gastrointestinal disorder—Epirubicin—bone cancer	0.000122	0.000842	CcSEcCtD
Darunavir—Fatigue—Epirubicin—bone cancer	0.000122	0.000841	CcSEcCtD
Darunavir—Pain—Epirubicin—bone cancer	0.000121	0.000834	CcSEcCtD
Darunavir—Constipation—Epirubicin—bone cancer	0.000121	0.000834	CcSEcCtD
Darunavir—Urticaria—Methotrexate—bone cancer	0.00012	0.000828	CcSEcCtD
Darunavir—Abdominal pain—Methotrexate—bone cancer	0.00012	0.000824	CcSEcCtD
Darunavir—Body temperature increased—Methotrexate—bone cancer	0.00012	0.000824	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000119	0.000822	CcSEcCtD
Darunavir—Insomnia—Doxorubicin—bone cancer	0.000119	0.000816	CcSEcCtD
Darunavir—Paraesthesia—Doxorubicin—bone cancer	0.000118	0.00081	CcSEcCtD
Darunavir—Dyspnoea—Doxorubicin—bone cancer	0.000117	0.000805	CcSEcCtD
Darunavir—Feeling abnormal—Epirubicin—bone cancer	0.000117	0.000804	CcSEcCtD
Darunavir—Somnolence—Doxorubicin—bone cancer	0.000117	0.000802	CcSEcCtD
Darunavir—Gastrointestinal pain—Epirubicin—bone cancer	0.000116	0.000798	CcSEcCtD
Darunavir—Dyspepsia—Doxorubicin—bone cancer	0.000115	0.000794	CcSEcCtD
Darunavir—Decreased appetite—Doxorubicin—bone cancer	0.000114	0.000785	CcSEcCtD
Darunavir—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000113	0.000779	CcSEcCtD
Darunavir—Fatigue—Doxorubicin—bone cancer	0.000113	0.000778	CcSEcCtD
Darunavir—Urticaria—Epirubicin—bone cancer	0.000113	0.000775	CcSEcCtD
Darunavir—Constipation—Doxorubicin—bone cancer	0.000112	0.000772	CcSEcCtD
Darunavir—Pain—Doxorubicin—bone cancer	0.000112	0.000772	CcSEcCtD
Darunavir—Body temperature increased—Epirubicin—bone cancer	0.000112	0.000771	CcSEcCtD
Darunavir—Abdominal pain—Epirubicin—bone cancer	0.000112	0.000771	CcSEcCtD
Darunavir—Hypersensitivity—Methotrexate—bone cancer	0.000112	0.000768	CcSEcCtD
Darunavir—Asthenia—Methotrexate—bone cancer	0.000109	0.000748	CcSEcCtD
Darunavir—Feeling abnormal—Doxorubicin—bone cancer	0.000108	0.000744	CcSEcCtD
Darunavir—Gastrointestinal pain—Doxorubicin—bone cancer	0.000107	0.000738	CcSEcCtD
Darunavir—Pruritus—Methotrexate—bone cancer	0.000107	0.000737	CcSEcCtD
Darunavir—Hypersensitivity—Epirubicin—bone cancer	0.000104	0.000719	CcSEcCtD
Darunavir—Urticaria—Doxorubicin—bone cancer	0.000104	0.000717	CcSEcCtD
Darunavir—Abdominal pain—Doxorubicin—bone cancer	0.000104	0.000714	CcSEcCtD
Darunavir—Body temperature increased—Doxorubicin—bone cancer	0.000104	0.000714	CcSEcCtD
Darunavir—Diarrhoea—Methotrexate—bone cancer	0.000104	0.000713	CcSEcCtD
Darunavir—Asthenia—Epirubicin—bone cancer	0.000102	0.0007	CcSEcCtD
Darunavir—Pruritus—Epirubicin—bone cancer	0.0001	0.00069	CcSEcCtD
Darunavir—Dizziness—Methotrexate—bone cancer	0.0001	0.000689	CcSEcCtD
Darunavir—Diarrhoea—Epirubicin—bone cancer	9.7e-05	0.000667	CcSEcCtD
Darunavir—Hypersensitivity—Doxorubicin—bone cancer	9.66e-05	0.000665	CcSEcCtD
Darunavir—Vomiting—Methotrexate—bone cancer	9.63e-05	0.000663	CcSEcCtD
Darunavir—Rash—Methotrexate—bone cancer	9.55e-05	0.000657	CcSEcCtD
Darunavir—Dermatitis—Methotrexate—bone cancer	9.54e-05	0.000657	CcSEcCtD
Darunavir—Headache—Methotrexate—bone cancer	9.49e-05	0.000653	CcSEcCtD
Darunavir—Asthenia—Doxorubicin—bone cancer	9.41e-05	0.000648	CcSEcCtD
Darunavir—Dizziness—Epirubicin—bone cancer	9.37e-05	0.000645	CcSEcCtD
Darunavir—Pruritus—Doxorubicin—bone cancer	9.28e-05	0.000639	CcSEcCtD
Darunavir—Vomiting—Epirubicin—bone cancer	9.01e-05	0.00062	CcSEcCtD
Darunavir—Nausea—Methotrexate—bone cancer	9e-05	0.000619	CcSEcCtD
Darunavir—Diarrhoea—Doxorubicin—bone cancer	8.97e-05	0.000618	CcSEcCtD
Darunavir—Rash—Epirubicin—bone cancer	8.94e-05	0.000615	CcSEcCtD
Darunavir—Dermatitis—Epirubicin—bone cancer	8.93e-05	0.000614	CcSEcCtD
Darunavir—Headache—Epirubicin—bone cancer	8.88e-05	0.000611	CcSEcCtD
Darunavir—Dizziness—Doxorubicin—bone cancer	8.67e-05	0.000597	CcSEcCtD
Darunavir—Nausea—Epirubicin—bone cancer	8.42e-05	0.000579	CcSEcCtD
Darunavir—Vomiting—Doxorubicin—bone cancer	8.34e-05	0.000574	CcSEcCtD
Darunavir—Rash—Doxorubicin—bone cancer	8.27e-05	0.000569	CcSEcCtD
Darunavir—Dermatitis—Doxorubicin—bone cancer	8.26e-05	0.000569	CcSEcCtD
Darunavir—Headache—Doxorubicin—bone cancer	8.22e-05	0.000565	CcSEcCtD
Darunavir—Nausea—Doxorubicin—bone cancer	7.79e-05	0.000536	CcSEcCtD
